17:00 EDT CG Oncology (CGON) files automatic mixed securities shelf
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CGON:
- Promising Clinical Data and Strong Financials Support Buy Rating for CG Oncology
- CG Oncology reports FY24 EPS ($1.41) vs ($15.65) last year
- Promising Phase 3 Trial Results and Strong Market Potential Drive Buy Rating for CG Oncology
- Buy Rating for CG Oncology: Promising Phase 3 Results and Strong Safety Profile of Cretostimogene
- Buy Rating for CG Oncology Backed by Promising Phase 3 Study Results and Strong Safety Profile
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue